Sex Hormone Binding Globulin: the Carrier Protein for D-norgestrel
Overview
Authors
Affiliations
The binding of different synthetic steroids, used in hormonal contraception, to Sex Hormone Binding Globulin (SHBG) was studied by measuring their ability to displace tritiated testosterone from SHBG in a competitive protein binding system. Only 19-nortestosterone derivates had any significant ability to displace testosterone from SHBG, d-norgestrel (d-Ng) being the strongest displacer. Increasing the SHBG levels in women with previous constant plasma d-Ng levels increased these levels two- to sixfold. It is concluded that SHBG is the main carrier protein for d-Ng. The strong testosterone displacing activity of d-Ng might also explain androgenic side effects observed with d-Ng containig oral contraceptives.
Kailasam C, Akande V, Gordon U J Assist Reprod Genet. 2005; 22(3):137-40.
PMID: 16018245 PMC: 3455176. DOI: 10.1007/s10815-005-4889-3.
Levonorgestrel. Clinical pharmacokinetics.
FOTHERBY K Clin Pharmacokinet. 1995; 28(3):203-15.
PMID: 7758251 DOI: 10.2165/00003088-199528030-00003.
Jejunoileal bypass. Long-term results.
ORGAN Jr C, Cegielski M, Grabner B, Keig H, SAPORTA J Ann Surg. 1980; 192(1):38-43.
PMID: 7406562 PMC: 1344803. DOI: 10.1097/00000658-198007000-00007.
Orme M Br J Clin Pharmacol. 1982; 14(1):31-42.
PMID: 7049209 PMC: 1427581. DOI: 10.1111/j.1365-2125.1982.tb04931.x.
Damber J, Bergman B, Sodergard R, Tomic R J Endocrinol Invest. 1983; 6(2):91-4.
PMID: 6683289 DOI: 10.1007/BF03350578.